相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
Theodoros Karantanos et al.
EUROPEAN UROLOGY (2015)
Steap4 attenuates high glucose and S100B-induced effects in mesangial cells
Chao-Tang Chuang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Heteronemin, a Spongean Sesterterpene, Induces Cell Apoptosis and Autophagy in Human Renal Carcinoma Cells
Szu-Ying Wu et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells
Sakthivel Muniyan et al.
CANCER LETTERS (2014)
Heteronemin, a marine sponge terpenoid, targets TDP-43, a key factor in several neurodegenerative disorders
Chiara Cassiano et al.
CHEMICAL COMMUNICATIONS (2014)
Proopiomelanocortin gene delivery induces apoptosis in melanoma through NADPH oxidase 4-mediated ROS generation
Guei-Sheung Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1α
Chi Zhang et al.
TUMOR BIOLOGY (2014)
Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer
Zhiqiang Han et al.
ONCOTARGET (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
In vitro characterisation of the anti-intravasative properties of the marine product heteronemin
Sabine Kopf et al.
ARCHIVES OF TOXICOLOGY (2013)
Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor
Sachiyo Nishida et al.
CANCER SCIENCE (2013)
Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Transforming growth factor β in prostate cancer. Cellular effects and basic molecular mechanisms
M. B. Stope et al.
UROLOGE (2013)
Castration-resistant prostate cancer: systemic therapy in 2012
Fernando C. Maluf et al.
CLINICS (2012)
Small Molecule Inhibitors of STAT3 for Cancer Therapy
M. Zhao et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Systemic Pro-opiomelanocortin Expression Induces Melanogenic Differentiation and Inhibits Tumor Angiogenesis in Established Mouse Melanoma
Guei-Sheung Liu et al.
HUMAN GENE THERAPY (2011)
Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
Geert J. L. H. van Leenders et al.
PLOS ONE (2011)
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression
Chang-Il Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death
Marc Schumacher et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Mara P. Steinkamp et al.
CANCER RESEARCH (2009)
Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock
Zsolt Bikadi et al.
JOURNAL OF CHEMINFORMATICS (2009)
Stat3 promotes metastatic progression of prostate cancer
Junaid Abdulghani et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells
Ajay P. Singh et al.
CANCER LETTERS (2008)
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Khandaker Al Zaid Siddiquee et al.
CELL RESEARCH (2008)
Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration
Carmen Eckerich et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity
Khandaker Siddiquee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
From Tpr-Met to Met, tumorigenesis and tubes
P. Peschard et al.
ONCOGENE (2007)
The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression
Meletios Verras et al.
CANCER RESEARCH (2007)
Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells
Carla Boccaccio et al.
NATURE REVIEWS CANCER (2006)
Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480
Peter A. Humphrey et al.
CLINICAL GENITOURINARY CANCER (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Up-regulation of c-met protooncogene product expression through hypoxia-inducible factor-1α is involved in trophoblast invasion under low-oxygen tension
M Hayashi et al.
ENDOCRINOLOGY (2005)
The stats of cancer - New molecular targets come of age
H Yu et al.
NATURE REVIEWS CANCER (2004)
Expression and function of androgen receptor coactivators in prostate cancer
Z Culig et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Androgen receptor gene amplification and protein expression in recurrent prostate cancer
OH Ford et al.
JOURNAL OF UROLOGY (2003)
The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function
B Comuzzi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer
M Naughton et al.
JOURNAL OF UROLOGY (2001)
分享论文
